Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access

Sep.24
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.

Key Points

  • Health Minister Marjorie Michel said she is not considering loosening nicotine pouch retail restrictions.
  • Pouches containing 4 mg or less of nicotine per unit are non-prescription NRTs in Canada; products above that threshold are prescription drugs.
  • Newer NRT formats such as nicotine pouches must generally be sold behind pharmacy counters, rather than through self-selection in general retail.
  • Unsmoke Canada is campaigning for broader retail access. The group is part of the Rothmans, Benson & Hedges structure, PMI's Canadian subsidiary.
  • Among Canadians aged 16 to 19, reported ever use of nicotine pouches rose from 2.0% in 2023 to 5.3% in 2024, while past-30-day use rose from 1.0% to 2.5%.

2Firsts

September 24, 2026

According to The Canadian Press on September 23, Canadian Health Minister Marjorie Michel said she is not considering loosening the country's retail restrictions on nicotine pouches, responding to calls from a Philip Morris International-linked group, convenience retailers and some political figures for wider access.

Michel also acknowledged that unauthorized nicotine pouches entering Canada through online and physical retail channels remain an issue, but did not indicate that the government would address the problem by relaxing current sales rules.

Pouches at 4 mg or Below Are Regulated as Smoking-Cessation Products

Canada does not impose a blanket ban on nicotine pouches. Products that meet regulatory requirements are treated as nicotine replacement therapy, or NRT.

Health Canada clarified in January 2026 that buccal nicotine pouches containing 4 mg or less per dosage unit are non-prescription products. Pouches above 4 mg per unit fall under prescription-drug status. Authorized pouches are intended as smoking-cessation products for adults aged 18 and older.

New and emerging NRT dosage forms that are not on Health Canada's self-selection list, including nicotine pouches, generally may be sold only by pharmacists or people under pharmacist supervision and must be kept inaccessible for consumer self-selection, such as behind the pharmacy counter. Online pharmacy sales also require pharmacist intervention.

Rules introduced in 2024 also restrict these products to mint, menthol or a combination of the two, and require front-of-pack nicotine addiction warnings and clear identification as smoking-cessation aids for adults.

PMI-Linked Group Pushes for General Retail Access

Unsmoke Canada is campaigning to allow nicotine pouches to return to convenience stores and other general retail outlets.

The group says limiting pouches to pharmacies creates access barriers for adult smokers seeking cessation products and argues they should be sold in outlets where cigarettes are available.

The Canadian Press reports that Unsmoke Canada is part of Rothmans, Benson & Hedges, PMI's Canadian subsidiary. The group has used advertising and policy advocacy to press for changes to the current rules and links wider legal access to efforts to reduce the unauthorized market.

The campaign has also drawn support from some retailers and Conservative political figures. Canada's Conservative Party has separately promoted a "Free the Zyn" campaign calling for wider adult access to nicotine pouches.

ZONNIC Remains an Authorized, Marketed Nicotine Pouch

Health Canada's Licensed Natural Health Products Database lists ZONNIC Nicotine Pouches as actively licensed and marketed, with 4 mg of nicotine per pouch and Nicoventures Trading Limited as the licence holder.

Imperial Tobacco Canada has said Nicoventures Trading Limited is a subsidiary of its parent company British American Tobacco, and that Imperial Tobacco Canada is ZONNIC's exclusive Canadian distributor.

ZONNIC is licensed as nicotine replacement therapy to help adults quit smoking by reducing cravings and withdrawal symptoms.

That creates a notable competitive structure in the Canadian pouch market: a BAT-group company currently holds the licence for a marketed pouch product, while a PMI-linked advocacy group is pushing for broader retail access for the category.

Health Canada Says Unauthorized Products Remain on the Market

Health Canada has previously said it continues to receive reports of unauthorized nicotine products, including pouches, being sold at convenience stores, gas stations, other retailers and online.

The agency advises consumers to use only authorized products, saying unauthorized products have not been assessed for safety, efficacy and quality.

Michel also acknowledged this week that the government cannot track every unauthorized product entering or circulating in the market.

Unsmoke Canada argues that wider access to authorized products would help reduce the illicit market. Tobacco-control groups take a different position, calling for stronger enforcement rather than weaker retail rules. The Canadian Press quoted Flory Doucas, co-director of the Quebec Coalition for Tobacco Control, as saying enforcement failures should not be used to justify weakening regulation.

Youth Nicotine Pouch Use Has Increased

Rising pouch use among young people is part of the public-health backdrop to Canada's current restrictions.

A repeat cross-sectional study using the International Tobacco Control Youth Tobacco and Vaping Survey found that ever use of nicotine pouches among Canadians aged 16 to 19 increased from 2.0% in 2023 to 5.3% in 2024.

Past-30-day use in the same age group increased from 1.0% to 2.5%.

Among Canadians aged 20 to 29, ever use was 9.1% in 2024 and past-30-day use was 4.2%.

The study covered Canada, England, the United States and New Zealand and found rising pouch use among young people across multiple markets. The survey data do not distinguish all use by whether the products were locally authorized.

Debate Centers on Retail Access Versus Enforcement

The Canadian policy dispute is increasingly focused less on whether authorized pouches may exist and more on how they should be sold.

Unsmoke Canada and some retail and political groups argue that pharmacy-only access makes authorized cessation products harder for adult smokers to obtain and leaves room for unauthorized products.

Michel has not adopted that approach. She said the government is not currently considering looser retail rules.

Unless the policy changes, authorized nicotine pouches in Canada will remain regulated under the NRT framework, including pharmacy-counter, flavour and labeling restrictions.

Follow 2Firsts for updates on global nicotine pouch regulation, market access and retail policy.

Cover Image generated by AI


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
British e-liquid manufacturer Riot Labs has introduced a fictional “candidate” called Riot Man around the Clacton parliamentary by-election, seeking to mobilize consumers and retailers against parts of the UK government’s proposed restrictions on vape packaging, device appearance and retail displays. Riot Man is not listed as an official candidate.
Aug.12
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20